Phreesia, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Phreesia, Inc. stockholders re-elected directors, ratified auditors, and approved executive compensation at the 2026 annual meeting.
NYSE
Phreesia, Inc. announced robust first-quarter fiscal 2027 financial results, showcasing significant year-over-year growth in revenue, net income, and adjusted EBITDA.
NYSE
Phreesia, Inc. has implemented a restructuring plan to reduce operating expenses, including the elimination of approximately 220 positions.
NYSE
Phreesia, Inc. announced an amendment to its receivables purchase agreement, increasing the facility limit to $300 million and extending the termination date to April 30, 2029.
NYSE
Phreesia announces positive GAAP net income and record free cash flow for FY2026, while revising FY2027 revenue guidance downwards due to shorter visibility in network solutions.
NYSE
Phreesia, Inc. secured a new $275 million revolving credit facility, replacing its existing bridge loan and asset-based facility, enhancing financial flexibility and reducing borrowing costs.
NYSE
Phreesia, Inc. announced the appointment of Jon Kessler to its Board of Directors, effective April 6, 2026, while Edward L. Cahill and Michael Weintraub will retire at the 2026 Annual Meeting.
NYSE
AccessOne Parent Holdings, Inc. reported a significant turnaround to profitability in 2024 with increased cash flow, preceding its acquisition by Phreesia, Inc. for $160 million.
NYSE
Phreesia announced robust third-quarter fiscal 2026 results, exceeding revenue and Adjusted EBITDA expectations, and completed its strategic $160 million acquisition of AccessOne, enhancing its healthcare financing solutions.
NYSE
Phreesia, Inc. has successfully completed its acquisition of AccessOne Parent Holdings, Inc., funding a portion of the $163 million cash consideration with a new $110 million secured bridge loan.
NYSE
Phreesia announced its first net income positive quarter and a definitive agreement to acquire AccessOne for $160 million, expanding its healthcare payment solutions.
NYSE
Phreesia, Inc. announced the results of its annual meeting of stockholders held on June 25, 2025, where all three proposals, including the election of two Class III directors, the ratification of KPMG LLP as its independent auditor, and the advisory approval of executive compensation, were passed.
NYSE
Phreesia, Inc. announced robust financial results for its fiscal first quarter ended April 30, 2025, showcasing substantial improvements in profitability and cash flow, leading to an upward revision of its fiscal year 2026 Adjusted EBITDA guidance.
NYSE
Phreesia reports a strong finish to fiscal 2025 with revenue growth, improved profitability, and maintains its fiscal 2026 outlook.
NYSE
Phreesia announced a 17% year-over-year revenue increase for the third quarter of fiscal year 2025, driven by growth in network solutions and subscription services, and raised its full-year outlook.
NYSE
Phreesia announced positive free cash flow for the first time as a public company in the second quarter of fiscal year 2025, alongside a 19% year-over-year revenue increase.
NYSE
Phreesia, Inc. held its annual meeting of stockholders on June 26, 2024, where directors were elected, the appointment of the independent auditor was ratified, and executive compensation was approved.
NYSE
Phreesia, Inc. has appointed Yvonne Hui as its new Principal Accounting Officer, effective June 20, 2024, replacing Janet Gunzburg.
NYSE
Phreesia reports a return to profitability in the first quarter of fiscal year 2025, with revenue up 21% year-over-year, while also updating its full-year revenue and Adjusted EBITDA outlook.
NYSE
Phreesia announced its fiscal year 2024 results, highlighting a 27% revenue increase and a strategic move to establish a subsidiary in India, while projecting a return to profitability in fiscal year 2025.